MEDICALLY REVIEWED

Gadopiclenol (Eluciremâ„¢) for Contrast-Enhanced MRI

MRI
The US FDA granted regulatory approval to Gadopiclenol (Eluciremâ„¢), a new macrocyclic GBCA for use in adults and children aged 2 years and older, for contrast-enhanced MRI.

Log In or Register as a healthcare professional to read the full article.

Share via

Also worth reading

People also read: